NDC 65219-552
Pralatrexate
Pralatrexate
Pralatrexate is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Pralatrexate.
| Product ID | 65219-552_510bc71b-20e4-428a-8fc2-29c9fc20f2f3 |
| NDC | 65219-552 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pralatrexate |
| Generic Name | Pralatrexate |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-11-15 |
| Marketing Category | NDA AUTHORIZED GENERIC / |
| Application Number | NDA022468 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | PRALATREXATE |
| Active Ingredient Strength | 40 mg/2mL |
| Pharm Classes | Folate Analog Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |